GLIOBLASTOMA MULTIFORME, ADULT
Clinical trials for GLIOBLASTOMA MULTIFORME, ADULT explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME, ADULT trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Adaptive radiation aims to outsmart aggressive brain tumors
Disease control OngoingThis study tests whether a personalized, two-phase radiation therapy approach can better control glioblastoma, an aggressive brain cancer. The treatment adapts the radiation plan based on tumor changes during therapy, potentially targeting the tumor more precisely while sparing h…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jul 02, 2026 02:00 UTC
-
New radiation boost shows promise for elderly glioblastoma patients
Disease control OngoingThis phase 2 trial tests a higher radiation dose given over just 3 weeks for patients 65 and older with glioblastoma or grade 4 astrocytoma. Using a special MRI-guided machine (MR-Linac), doctors can adjust the radiation daily to target the tumor more precisely. The goal is to se…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for glioblastoma: experimental drug berubicin faces key trial
Disease control OngoingThis Phase 2 trial tests an experimental chemotherapy drug called berubicin against a standard drug (lomustine) in 252 adults with recurrent glioblastoma, a severe brain cancer. The goal is to see if berubicin can help patients live longer after standard first-line treatment has …
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: CNS Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC